3 Undervalued Health Care Providers & Services Stocks for Friday, August 14
Discover the top 3 undervalued Health Care Providers & Services stocks for Friday, August 14 based on AAII’s Stock Grades.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.
Commentary & Analysis
Why Nutex Health Inc.’s (NUTX) Stock Is Up 5.39%
As of Thursday, August 13, Nutex Health Inc.’s NUTX share price has surged by 5.39%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Nutex Health Inc.’s (NUTX) Stock Is Down 8.31%
As of Tuesday, August 11, Nutex Health Inc.’s NUTX share price has dipped by 8.31%, which has investors questioning if this is right time to buy.Michael Rose
Why Nutex Health Inc.’s (NUTX) Stock Is Down 14.63%
As of Tuesday, August 11, Nutex Health Inc.’s NUTX share price has dipped by 14.63%, which has investors questioning if this is right time to buy.Tudor Pop
Why Nutex Health Inc.’s (NUTX) Stock Is Up 9.11%
As of Monday, August 10, Nutex Health Inc.’s NUTX share price has surged by 9.11%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Financial Summary
| Share Statistics | NUTX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,291.1 | $1,982.5 | 48% |
|
| Shares Out (Mil) | 7.0 | 77.7 | 16% |
|
| Institutional Ownership | 52.1% | 86.1% | 36% |
|
| Float (Mil) | 4.1 | 52.1 | 10% |
|
| Beta | na | 0.75 | na |
|
| Avg Daily Volume (000s) | 190 | 637 | 43% |
|
| Price Change (52-week) |
98.6% | 79.7% | 90% |
|
| Growth | NUTX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 26.1% | 10.9% | 87% |
|
| Net Income (5yr) | (7.8%) | (1.6%) | 31% |
|
| EPS (5yr) | (17.1%) | 0.3% | 16 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 38.7% | (17.9%) | 90% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | $4.954 | $28.300 | $28.828 | |
| Month Ago EPS | na | na | na | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 0 | 0 | 1 | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | (47.2%) | 170.0% | 141.8% | |
| Financials | NUTX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $847 | $1,504 | 48% |
|
| Net Income (TTM) (Mil) | $180 | $28 | 67% |
|
| EPS (TTM) | $26.346 | $0.200 | 99% |
|
| Operating Cash Flow (TTM) (Mil) | $280 | $162 | 63% |
|
| Net Cash Flow (TTM) (Mil) | $110 | $9 | 78% |
|
| Long-Term Debt (Q1) (Mil) | $329 | $338 | 54% |
|
| Enterprise Value (Q1) (Mil) | na | $2,416 | na |
|
| Valuation | NUTX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.27 | 2.79 | 67% |
|
| P/E | 7.5 | 25.8 | 9% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | NUTX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 54.5% | 27.8% | 66% |
|
| Net Margin | 21.2% | 1.2% | 80% |
|
| ROA | 19.9% | 2.2% | 96% |
|
| ROE | 57.2% | 7.2% | 94% |
|
| Liabilities to Assets | 47.4% | 58.6% | 39% |
|
| F-Score | 6 | 5 | 67% |
|
Passing Stock Screens
As of 8/20/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
Fundamental Rule of Thumb Screen
Factors: Value
An old value screen combining the P/E ratio, dividend yield, and an adjusted return on equity that's still applicable in today's market.
| Performance Since Inception: | 6.6% |
| +/- S&P 500: | -0.9 |
GURU STRATEGY
Kirkpatrick Bargain Screen
Factors: Value, Momentum
Investing model outlined in Charles Kirkpatrick's book, Beat the Market: Invest by Knowing What Stocks to Buy and What Stocks to Sell.
| Performance Since Inception: | 6.8% |
| +/- S&P 500: | -0.7 |
GURU STRATEGY
Magic Formula Screen
Factors: Value, Quality
Joel Greenblatt's investing approach is based on finding companies with high return on investment that are trading for less than they are worth.
| Performance Since Inception: | 6.8% |
| +/- S&P 500: | -0.7 |
GURU STRATEGY
O'Shaughnessy: Small Cap Growth & Value Screen
Factors: Value, Size, Momentum
O'Shaughnessy tries to predict the future using historical long-term trends.
| Performance Since Inception: | 17.3% |
| +/- S&P 500: | +9.8 |
